SlideShare a Scribd company logo
Noida Institute of Engineering and Technology (Pharmacy Institute)
Greater Noida
AN AUTONOMUS INSTITUTE
TOXICOKINETICS & SATURATION KINETICS
Presented by:-
Shilajit Das(2nd Sem)
M . Pharm (Pharmacology)
Submitted to:-
Dr . Saumya Das
Associate Professor
NIET(Pharmacy Institute)
Greater Noida
Introduction
• Toxicokinetics is defined as the generation of
pharmacokinetics data to design, conduct &
Interpretation of drug safety evaluation studies.
• In these studies, a minimum of two animal species
are employed, as per regulation of FDA.
1. Rodents(rat and mice )
2. Non-rodents(dogs)
2
Need of toxicokinetic Studies
• Generation of kinetic data for systemic exposure and
toxicity assessment of the drug.
• Safety/risk ratio
• Important in drug development stages especially in
preclinical stage.
• Useful for the setting safe dose level in clinical phases.
3
Objectives
To describe the systemic exposure achieved in
animals and its relationship to dose level and time
course of the toxicity study.
To relate the exposure achieved in toxicity studies to
toxicological findings and contribute to assessment of
human safety clinically.
To provide information which, in conjunction with the
toxicity findings contributes to the design of
subsequent non- clinical toxicity studies.
4
Toxicokinetic study goals
A. Pretoxicology study
• Recommend selection of species
• Route selection
• Develop data for dose selection
B. Toxicology study
• Provide estimate of internal dose
• Determine effects of age and
multiple
• Exposure on kinetics
General principles of TK studies
A. Quantification of exposure
B. Justification of time points for sampling
C. Dose level toxicity testing
D. Ratifying factor
E. Route of administration
F. Determination of metabolites
G. Statistical evaluation of data
H. Analytical methods
I. Reporting
6
Protocol for toxicokinetic validation
7
Rational
Selection of animal
Preliminary study
Chronic study
Main study
Methods of Evaluation
Statistical Analysis
Results of Reporting
Applications of toxicokinetic studies
 TK evaluation is useful in selection of
 Dose
 Dosing of form
 alternative dosing route
 evaluation of toxicological mechanism
 use for the setting safe dose level in clinical phase
 TK studies also used to reduces the animal number.
 TK evaluation is very important in drug development phase in both regulatory
and scientific perspective
 TK data are practically used for the purpose of drug discovery such as lead
optimization and candidate- selection
8
Drugs monitored for its toxicity
9
Saturation Kinetics
10
 Also known as nonlinear pharmacokinetics.
 The rate of process of a drug’s ADME are
dependent upon carrier or enzymes that are
substrate- specific.
 Have definite capacities and susceptible to
saturation high drug concentration.
 In such cases an essentially first- order kinetics
transform into a mixture of first- order and zero-
order rate processes and PK parameters change
with size of the administered dose.
Detection of non-linearity In pharmacokinetics
Determine of steady state plasma concentration at different
doses
Determine of some important PK parameters such as
Fraction bioavailability
Elimination half life or total systemic clearance
Reference
12
• Barton, H.A.., et al.(2006) . Application of saturation , Metabolism and
Excretion(ADME)data in Agriculture chemical . Critical Revies in
Toxicology.36:9-35
• OECD Guideline for testing of chemical:- 428 “Skin Absorption : in vitro
method ”(Adopted 13 April 2004)
• Gingrich, J., Pu Y., Ehrhardt, R ., Karthik raj , R., Kannan
• Brahmankar ,D.M. and Jaiswal , S. B.(2009) Biopharmaceutics and
Pharmacokinetics, Delhi
THANK YOU

More Related Content

PPTX
Toxicology types and definition.pptx
PPTX
Regulatory terminology of ADR and Establishing pharmacovigilance center's i...
PPTX
Chronopharmacology of peptic ulcer
PDF
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
PPTX
Acute eye irritation OECD 405 m pharm cology 2nd sem..pptx
PDF
Pharmacology of free radicals
PPTX
Toxicokinetic evaluation in preclinical studies.pptx
PPTX
Non adrenergic non cholinergic transmission(nanc)
Toxicology types and definition.pptx
Regulatory terminology of ADR and Establishing pharmacovigilance center's i...
Chronopharmacology of peptic ulcer
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
Acute eye irritation OECD 405 m pharm cology 2nd sem..pptx
Pharmacology of free radicals
Toxicokinetic evaluation in preclinical studies.pptx
Non adrenergic non cholinergic transmission(nanc)

What's hot (20)

PPTX
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
PPTX
Immunoassay of digoxin
PDF
Assignment on Toxicokinetics
PPTX
Toxicokinetic evaluation in preclinical studies.pptx
PPTX
Toxikokinetics
PPTX
Immunoassay of digoxin
PPTX
Teratogenicity.pptx
PPTX
Toxicokinetics in preclinical studies by Priyabrata Panda
PDF
PPTX
Acute dermal toxicity-402
PPTX
Importance of guidelines in regulatory toxicity testing
PPTX
Acute inhalational toxicity studies.pptx
PPTX
IN-VIVO CARCINOGENICITY STUDIES.pptx TG451
PPTX
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
PPTX
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
PPTX
IND Enabling Studies by Kashikant Yadav
PPTX
OECD Guideline For Acute oral toxicity (TG 423)
PPTX
CNS, RESPIRATORY & CVS (hERG assay) SAFETY PHARMACOLOGY STUDIES
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Immunoassay of digoxin
Assignment on Toxicokinetics
Toxicokinetic evaluation in preclinical studies.pptx
Toxikokinetics
Immunoassay of digoxin
Teratogenicity.pptx
Toxicokinetics in preclinical studies by Priyabrata Panda
Acute dermal toxicity-402
Importance of guidelines in regulatory toxicity testing
Acute inhalational toxicity studies.pptx
IN-VIVO CARCINOGENICITY STUDIES.pptx TG451
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
IND Enabling Studies by Kashikant Yadav
OECD Guideline For Acute oral toxicity (TG 423)
CNS, RESPIRATORY & CVS (hERG assay) SAFETY PHARMACOLOGY STUDIES
Ad

Similar to presentation.pptx (20)

PPTX
PTSM 2.pptx
PPTX
toxicokinetics and saturation kinetics
PPTX
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
PPTX
Safety guidelines- S3A and S3B
PPTX
Ich guidelines
PPTX
toxicokinetic evaluation and pharmacokinetic.pptx
PPTX
Toxiocokinetic evaluation in preclinical studies.pptx
PPT
Bioanalysis significance 12 oct 2022.ppt
PPTX
Safety pharmacology
PPTX
Bioanlytical method development
PPTX
Special concerns in bioavaliblity and bioeqvivalence
PPTX
S7A safety pharmacological studies for pharamaceuticals.pptx
PPTX
THERAPEUTIC DRUG MONITORING S KOSEY
PPTX
Toxicokinetics in preclinical screening model .pptx
PPT
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
PDF
Different types of toxicity studies_131223.pdf
PPTX
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...
PPTX
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
 
PPTX
Safety Pharmacology Studies ICH guideline S7A
PPTX
Therapeutic drug monitoring
PTSM 2.pptx
toxicokinetics and saturation kinetics
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
Safety guidelines- S3A and S3B
Ich guidelines
toxicokinetic evaluation and pharmacokinetic.pptx
Toxiocokinetic evaluation in preclinical studies.pptx
Bioanalysis significance 12 oct 2022.ppt
Safety pharmacology
Bioanlytical method development
Special concerns in bioavaliblity and bioeqvivalence
S7A safety pharmacological studies for pharamaceuticals.pptx
THERAPEUTIC DRUG MONITORING S KOSEY
Toxicokinetics in preclinical screening model .pptx
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Different types of toxicity studies_131223.pdf
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
 
Safety Pharmacology Studies ICH guideline S7A
Therapeutic drug monitoring
Ad

Recently uploaded (20)

PDF
FORM 1 BIOLOGY MIND MAPS and their schemes
PDF
AI-driven educational solutions for real-life interventions in the Philippine...
PDF
BP 704 T. NOVEL DRUG DELIVERY SYSTEMS (UNIT 1)
PPTX
History, Philosophy and sociology of education (1).pptx
PDF
Weekly quiz Compilation Jan -July 25.pdf
PPTX
Introduction to Building Materials
DOC
Soft-furnishing-By-Architect-A.F.M.Mohiuddin-Akhand.doc
PPTX
Computer Architecture Input Output Memory.pptx
PDF
advance database management system book.pdf
PDF
RTP_AR_KS1_Tutor's Guide_English [FOR REPRODUCTION].pdf
PDF
CISA (Certified Information Systems Auditor) Domain-Wise Summary.pdf
PDF
MBA _Common_ 2nd year Syllabus _2021-22_.pdf
PDF
احياء السادس العلمي - الفصل الثالث (التكاثر) منهج متميزين/كلية بغداد/موهوبين
PPTX
CHAPTER IV. MAN AND BIOSPHERE AND ITS TOTALITY.pptx
PPTX
202450812 BayCHI UCSC-SV 20250812 v17.pptx
PPTX
Chinmaya Tiranga Azadi Quiz (Class 7-8 )
PDF
Chinmaya Tiranga quiz Grand Finale.pdf
PDF
IGGE1 Understanding the Self1234567891011
PDF
Black Hat USA 2025 - Micro ICS Summit - ICS/OT Threat Landscape
PDF
Τίμαιος είναι φιλοσοφικός διάλογος του Πλάτωνα
FORM 1 BIOLOGY MIND MAPS and their schemes
AI-driven educational solutions for real-life interventions in the Philippine...
BP 704 T. NOVEL DRUG DELIVERY SYSTEMS (UNIT 1)
History, Philosophy and sociology of education (1).pptx
Weekly quiz Compilation Jan -July 25.pdf
Introduction to Building Materials
Soft-furnishing-By-Architect-A.F.M.Mohiuddin-Akhand.doc
Computer Architecture Input Output Memory.pptx
advance database management system book.pdf
RTP_AR_KS1_Tutor's Guide_English [FOR REPRODUCTION].pdf
CISA (Certified Information Systems Auditor) Domain-Wise Summary.pdf
MBA _Common_ 2nd year Syllabus _2021-22_.pdf
احياء السادس العلمي - الفصل الثالث (التكاثر) منهج متميزين/كلية بغداد/موهوبين
CHAPTER IV. MAN AND BIOSPHERE AND ITS TOTALITY.pptx
202450812 BayCHI UCSC-SV 20250812 v17.pptx
Chinmaya Tiranga Azadi Quiz (Class 7-8 )
Chinmaya Tiranga quiz Grand Finale.pdf
IGGE1 Understanding the Self1234567891011
Black Hat USA 2025 - Micro ICS Summit - ICS/OT Threat Landscape
Τίμαιος είναι φιλοσοφικός διάλογος του Πλάτωνα

presentation.pptx

  • 1. Noida Institute of Engineering and Technology (Pharmacy Institute) Greater Noida AN AUTONOMUS INSTITUTE TOXICOKINETICS & SATURATION KINETICS Presented by:- Shilajit Das(2nd Sem) M . Pharm (Pharmacology) Submitted to:- Dr . Saumya Das Associate Professor NIET(Pharmacy Institute) Greater Noida
  • 2. Introduction • Toxicokinetics is defined as the generation of pharmacokinetics data to design, conduct & Interpretation of drug safety evaluation studies. • In these studies, a minimum of two animal species are employed, as per regulation of FDA. 1. Rodents(rat and mice ) 2. Non-rodents(dogs) 2
  • 3. Need of toxicokinetic Studies • Generation of kinetic data for systemic exposure and toxicity assessment of the drug. • Safety/risk ratio • Important in drug development stages especially in preclinical stage. • Useful for the setting safe dose level in clinical phases. 3
  • 4. Objectives To describe the systemic exposure achieved in animals and its relationship to dose level and time course of the toxicity study. To relate the exposure achieved in toxicity studies to toxicological findings and contribute to assessment of human safety clinically. To provide information which, in conjunction with the toxicity findings contributes to the design of subsequent non- clinical toxicity studies. 4
  • 5. Toxicokinetic study goals A. Pretoxicology study • Recommend selection of species • Route selection • Develop data for dose selection B. Toxicology study • Provide estimate of internal dose • Determine effects of age and multiple • Exposure on kinetics
  • 6. General principles of TK studies A. Quantification of exposure B. Justification of time points for sampling C. Dose level toxicity testing D. Ratifying factor E. Route of administration F. Determination of metabolites G. Statistical evaluation of data H. Analytical methods I. Reporting 6
  • 7. Protocol for toxicokinetic validation 7 Rational Selection of animal Preliminary study Chronic study Main study Methods of Evaluation Statistical Analysis Results of Reporting
  • 8. Applications of toxicokinetic studies  TK evaluation is useful in selection of  Dose  Dosing of form  alternative dosing route  evaluation of toxicological mechanism  use for the setting safe dose level in clinical phase  TK studies also used to reduces the animal number.  TK evaluation is very important in drug development phase in both regulatory and scientific perspective  TK data are practically used for the purpose of drug discovery such as lead optimization and candidate- selection 8
  • 9. Drugs monitored for its toxicity 9
  • 10. Saturation Kinetics 10  Also known as nonlinear pharmacokinetics.  The rate of process of a drug’s ADME are dependent upon carrier or enzymes that are substrate- specific.  Have definite capacities and susceptible to saturation high drug concentration.  In such cases an essentially first- order kinetics transform into a mixture of first- order and zero- order rate processes and PK parameters change with size of the administered dose.
  • 11. Detection of non-linearity In pharmacokinetics Determine of steady state plasma concentration at different doses Determine of some important PK parameters such as Fraction bioavailability Elimination half life or total systemic clearance
  • 12. Reference 12 • Barton, H.A.., et al.(2006) . Application of saturation , Metabolism and Excretion(ADME)data in Agriculture chemical . Critical Revies in Toxicology.36:9-35 • OECD Guideline for testing of chemical:- 428 “Skin Absorption : in vitro method ”(Adopted 13 April 2004) • Gingrich, J., Pu Y., Ehrhardt, R ., Karthik raj , R., Kannan • Brahmankar ,D.M. and Jaiswal , S. B.(2009) Biopharmaceutics and Pharmacokinetics, Delhi